Again GF I disagree with your accounting treatment.
You say that there is a $US130 million hedging derivative liability on the Balance Sheet at Dec 2008.
If the NZ gold price & the US/NZ exchange rate don't vary over the next two years then there is definitely no hedging benefit/loss to the P&L Statement over that time.
The $US130 million liability gets extinguished from the Balance Sheet by OGC paying out $US130 million in cold hard CASH on a quarterly basis to the hedging counterparty.
They are essentially selling 300k ozs/pa at the spot price and from those proceeds paying out the $US130 million liability.
There is only an effect on the P&L Statement when the NZ gold price varies as the hedge price is set in NZ dollars.
- Forums
- ASX - By Stock
- OGC
- running the numbers
running the numbers, page-11
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OGC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online